Neuhauser-Eichner-Opitz syndrome

Neuhauser-Eichner-Opitz syndrome, also known as megalocornea-intellectual disability syndrome, is a rare genetic disorder characterized by the combination of megalocornea (abnormally large corneas), intellectual disability, and hypotonia (decreased muscle tone). The condition primarily affects the eyes, the central nervous system, and overall neurodevelopmental function. Megalocornea is typically present at birth and is a hallmark feature, with corneal diameters exceeding normal values without elevated intraocular pressure (distinguishing it from congenital glaucoma). Additional features may include short stature, seizures, and minor facial dysmorphisms. Some patients may also exhibit obesity and behavioral abnormalities. The syndrome affects both males and females and is thought to follow an autosomal recessive inheritance pattern in most reported families, though some cases have suggested X-linked inheritance. The condition is extremely rare, with only a limited number of cases described in the medical literature. The ICD-10 classification code G93.4 (encephalopathy, unspecified) reflects the neurological involvement seen in this condition. There is currently no specific cure or targeted therapy for Neuhauser-Eichner-Opitz syndrome. Management is supportive and symptomatic, focusing on ophthalmological monitoring, developmental support including speech and occupational therapy, seizure management with anticonvulsant medications when needed, and educational interventions tailored to the individual's cognitive abilities. Regular follow-up with a multidisciplinary team including ophthalmologists, neurologists, and developmental specialists is recommended.

Common questions about Neuhauser-Eichner-Opitz syndrome